Acasti Pharma Total Current Assets 2014-2024 | GRCE
Acasti Pharma total current assets from 2014 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
Acasti Pharma Annual Total Current Assets
(Millions of US $) |
| 2024 |
$24 |
| 2023 |
$29 |
| 2022 |
$45 |
| 2021 |
$62 |
| 2020 |
$18 |
| 2019 |
$28 |
| 2018 |
$7 |
| 2017 |
$8 |
| 2016 |
$9 |
| 2015 |
$9 |
| 2015 |
$ |
| 2014 |
$25 |
| 2014 |
$ |
| 2013 |
$6 |
| 2013 |
$ |
Acasti Pharma Quarterly Total Current Assets
(Millions of US $) |
| 2024-06-30 |
$20 |
| 2024-03-31 |
$24 |
| 2023-12-31 |
$27 |
| 2023-09-30 |
$29 |
| 2023-06-30 |
$24 |
| 2023-03-31 |
$29 |
| 2022-12-31 |
$33 |
| 2022-09-30 |
$38 |
| 2022-06-30 |
$41 |
| 2022-03-31 |
$45 |
| 2021-12-31 |
$49 |
| 2021-09-30 |
$55 |
| 2021-06-30 |
$60 |
| 2021-03-31 |
$62 |
| 2020-12-31 |
$30 |
| 2020-09-30 |
$14 |
| 2020-06-30 |
$14 |
| 2020-03-31 |
$18 |
| 2019-12-31 |
$22 |
| 2019-09-30 |
$21 |
| 2019-06-30 |
$21 |
| 2019-03-31 |
$28 |
| 2018-12-31 |
$36 |
| 2018-09-30 |
$6 |
| 2018-06-30 |
$11 |
| 2018-03-31 |
$7 |
| 2017-12-31 |
$10 |
| 2017-09-30 |
$5 |
| 2017-06-30 |
$6 |
| 2017-02-28 |
$8 |
| 2016-11-30 |
$5 |
| 2016-08-31 |
$7 |
| 2016-05-31 |
$7 |
| 2016-03-31 |
$7 |
| 2016-02-29 |
|
| 2015-12-31 |
$11 |
| 2015-09-30 |
$13 |
| 2015-06-30 |
$15 |
| 2015-03-31 |
$17 |
| 2014-12-31 |
$19 |
| 2014-09-30 |
$21 |
| 2014-06-30 |
$22 |
| 2014-03-31 |
$25 |
| 2014-02-28 |
|
| 2013-12-31 |
$5 |
| 2013-09-30 |
$5 |
| 2013-06-30 |
$5 |
| 2013-03-31 |
$6 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-GENERIC DRG |
$0.033B |
$0.000B |
|
Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid therapies. CaPre (R), Acasti's only prescription drug candidate, is being developed to help prevent and treat hypertriglyceridemia. ONEMIA (R) is a medical food and currently Acasti's only commercialized product. Acasti Pharma Inc. is headquartered in Laval, Canada.
|
